Herantis Pharma Oyj (HEL:HRTIS)
Finland · Delayed Price · Currency is EUR 1.780
0.00 (0.00%)
May 18, 2026, 6:11 PM EET
Herantis Pharma Oyj Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
47.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orion Oyj | 1.95B |
| Terveystalo Oyj | 1.24B |
| Pihlajalinna Oyj | 613.23M |
| Revenio Group Oyj | 111.05M |
| Optomed Oyj | 16.43M |
| Biohit Oyj | 15.73M |
| Nexstim | 12.41M |
| Modulight Oyj | 10.43M |
Herantis Pharma Oyj News
- 2 months ago - Herantis Pharma Oyj Earnings Call Transcript: H2 2025 - Transcripts
- 4 months ago - Herantis Pharma Oyj Phase 1b Biomarker Data Transcript - GuruFocus
- 4 months ago - Herantis Pharma Oyj Transcript: Study Result - Transcripts
- 7 months ago - Herantis Pharma Oyj Transcript: Study Result - Transcripts
- 9 months ago - Herantis Pharma Oyj Earnings Call Transcript: H1 2025 - Transcripts
- 1 year ago - Herantis Pharma Oyj Earnings Call Transcript: H2 2024 - Transcripts
- 1 year ago - Herantis Pharma Oyj Transcript: R&D Day 2024 - Transcripts
- 1 year ago - Herantis Pharma Oyj Earnings Call Transcript: H1 2024 - Transcripts